Autoimmune‐type atypical hemolytic uremic syndrome treated with eculizumab as first‐line therapy

E-ISSN： 1442-200x|57|2|313-317

ISSN： 1328-8067

Source： PEDIATRICS INTERNATIONAL, Vol.57, Iss.2, 2015-04, pp. : 313-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 3, 2015-03 ,pp. : 485-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical hemolytic uremic syndrome: Korean pediatric series

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 3, 2015-06 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical Hemolytic Uremic Syndrome: Update on the Complement System and What Is New

Nephron Clin Pract, Vol. 114, Iss. 4, 2010-01 ,pp. : c219-c235

Karger

Access to resources Recommend Favorite

Identification and Management of Atypical Hemolytic Uremic Syndrome Immediately Post–Heart Transplantation

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 30, Iss. 4, 2015-04 ,pp. : 373-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

Living‐donor kidney transplantation for atypical haemolytic uremic syndrome with pre‐emptive eculizumab use

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 3, 2015-03 ,pp. : 366-369

John Wiley & Sons Inc

Access to resources Recommend Favorite